Literature DB >> 5651876

Activity study of doxepin. A new antidepressant.

A J Krakowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5651876     DOI： 10.1016/S0033-3182(68)71880-6

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  4 in total

1.  The treatment of "anxiety-depression" via positive reinforcement and response cost.

Authors:  J J Reisinger
Journal:  J Appl Behav Anal       Date:  1972

Review 2.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

Review 3.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

4.  Some considerations on the role of benzodiazepines in the treatment of depression.

Authors:  G B Cassano; L Conti
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.